Want to see SLQT full AI Analyst Report?
SLQT Stock Chart & Stats
$0.72
$0.02(2.10%)
At close: 4:00 PM EDT
$0.72
$0.02(2.10%)
Day’s Range― - ―
52-Week Range$0.56 - $2.77
Previous CloseN/A
Volume334.21K
Average Volume (3M)1.74M
Market Cap
$123.28M
Enterprise Value$766.58
Total Cash (Recent Filing)$35.21M
Total Debt (Recent Filing)$403.13M
Price to Earnings (P/E)7.0
Beta1.59
Next Earnings
Aug 25, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.10
Shares Outstanding176,347,780
10 Day Avg. Volume907,222
30 Day Avg. Volume1,743,506
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)0.73
Price to Sales (P/S)0.27
P/FCF Ratio-30.25
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$4.00Price Target Upside455.56% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.13
Revenue Forecast (FY)$1.74B
Bulls Say, Bears Say
Bulls Say
Substantial Commissions Receivable/backbookA nearly $1B commissions receivable balance represents a large backbook of expected renewal cash flows and long-duration revenue rights. That recurring revenue asset improves visibility into multi-year cash generation, supporting deleveraging and funding of growth initiatives if persistency holds.
High, Consistent Senior Segment MarginsThe Senior segment’s sustained ~25%+ EBITDA margins across enrollment seasons indicate a structurally profitable core business. Durable profitability in Medicare-related distribution provides stable cash generation and margin resilience versus more cyclical lines, anchoring overall company earnings durability.
Scaling Healthcare Services (SelectRx)SelectRx’s double-digit membership growth and large increase in prescriptions shipped show operational scale and unit-cost leverage. Combined with facility efficiencies and a near-term EBITDA run-rate target, this supports durable margin expansion and diversified cash flow beyond core insurance commissions.
Bears Say
Weak Cash GenerationNegative operating and free cash flows in 2025 and TTM mean reported profitability has not consistently converted to cash. Persistent cash deficits increase refinancing and execution risk, constrain capital allocation, and could slow deleveraging or investments if cash conversion does not improve.
Earnings Quality Tied To Estimate AdjustmentsReliance on a sizable favorable estimate adjustment to commissions receivable to boost EBITDA highlights earnings volatility and sensitivity to persistency assumptions. Such accounting-driven uplifts can mask underlying operating trends and create uncertainty around sustainable cash flow realization.
Regulatory And PBM Headwinds To SelectRx RevenueThe Inflation Reduction Act’s pricing provisions and earlier PBM reimbursement actions materially reduced near-term top-line and required refunds. These structural regulatory and reimbursement shifts can persistently pressure SelectRx revenue and margins, complicating long-term forecasting and cash-flow durability.
SelectQuote News
SLQT FAQ
What was SelectQuote’s price range in the past 12 months?
SelectQuote lowest stock price was $0.56 and its highest was $2.77 in the past 12 months.
What is SelectQuote’s market cap?
SelectQuote’s market cap is $123.28M.
When is SelectQuote’s upcoming earnings report date?
SelectQuote’s upcoming earnings report date is Aug 25, 2026 which is in 12 days.
How were SelectQuote’s earnings last quarter?
SelectQuote released its earnings results on May 05, 2026. The company reported $0.11 earnings per share for the quarter, beating the consensus estimate of -$0.008 by $0.118.
Is SelectQuote overvalued?
According to Wall Street analysts SelectQuote’s price is currently Undervalued.
Does SelectQuote pay dividends?
SelectQuote does not currently pay dividends.
What is SelectQuote’s EPS estimate?
SelectQuote’s EPS estimate is -0.17.
How many shares outstanding does SelectQuote have?
SelectQuote has 176,347,780 shares outstanding.
What happened to SelectQuote’s price movement after its last earnings report?
SelectQuote reported an EPS of $0.11 in its last earnings report, beating expectations of -$0.008. Following the earnings report the stock price went up 52.522%.
Which hedge fund is a major shareholder of SelectQuote?
Currently, no hedge funds are holding shares in SLQT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SelectQuote Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (455.56% Upside)
$4.00 (455.56% Upside)
Hedge Fund Trend
Decreased
By 139.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.80%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.00%
Trailing 12-Months
Company Description
SelectQuote
SelectQuote, Inc. operates as a tech-driven, direct-to-consumer marketplace, offering a wide spectrum of insurance products to individuals throughout the United States. These policies are underwritten by a variety of insurance carriers. The company structures its operations across three core divisions: Senior, Life, and Auto & Home. Within its Senior segment, SelectQuote provides access to a comprehensive suite of health policies, including Medicare Advantage, Medicare Supplement, and Medicare Part D plans. This segment also features ancillary coverages such as prescription drug plans, dental, vision, and hearing benefits. The Life division concentrates on term life insurance offerings, while the Auto & Home segment delivers personal automobile, homeowners', and general casualty insurance solutions. Established in 1999, SelectQuote, Inc. is headquartered in Overland Park, Kansas.
SLQT Company Deck
SLQT Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid operational and financial progress: revenue grew 6% to $431M, adjusted EBITDA rose 18% to $45M, Senior and Healthcare Services showed tangible improvements, SelectRx demonstrated membership and efficiency momentum, and management reiterated guidance and a path to stronger cash flow in fiscal 2027. Offsetting items include IRA-driven top-line effects, earlier PBM reimbursement headwinds (now reportedly stabilized), reliance on a $14M favorable change in estimate that aided results, and potential timing-related volatility in MA approval rates that could affect Q4. Management emphasized backbook visibility (nearly $1B commissions receivable) and multiple strategic options to close the valuation gap. On balance, operational strengths and clear pathways to improved cash flow outweigh the near-term headwinds and accounting nuances.View all SLQT earnings summariesSLQT Stock 12 Month Forecast
Average Price Target
$4.00
▲(455.56% Upside)
Technical Analysis
Ownership Overview
30.65% Insiders
7.09% Mutual Funds
2.34% Other Institutional Investors
55.21% Public Companies and
Individual Investors